Stay updated on Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.

Latest updates to the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedThe NIH website transition announcement banner was removed; the page otherwise shows a 403 error instead of the clinical trial record.SummaryDifference1%

- Check13 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer site revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content, indicating an access restriction rather than substantive changes to the trial information.SummaryDifference20%

Stay in the know with updates to Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo and Bemcentinib for Pancreatic Cancer Clinical Trial page.